Approximately one in five individuals experience alveolar osteitis (AO) following wisdom tooth extraction. AO is characterised by loss of the blood clot from the tooth extraction socket leading to infection and pain, resulting in repeated hospital visits that impose a substantial burden on healthcare systems. Current treatments are sub-optimal; to address this we developed a novel drug-loaded mucoadhesive patch composed of dual electrospun polyvinyl pyrrolidone/Eudragit RS100 (PVP/RS100) and poly(N-isopropylacrylamide) (PNIPAM) fibres protected by a poly(ε-caprolactone) (PCL) backing layer.
View Article and Find Full Text PDFThe accurate computational treatment of polycrystalline materials requires the rigorous generation of grain boundary (GB) structures as many quantities of interest depend strongly on the specifics of the macroscopic and microscopic degrees of freedom (DoFs) used in their creation. In complex materials, containing multiple sublattices and where atomic composition can vary spatially through the system, we introduce a new microscopic DoF based on this compositional variation which we find governs observable properties. In spinel - a wide class of complex oxides where this compositional variation manifests as cation inversion - we exploit this DoF to generate and analyze low-energy microstates of two GBs with three spinel chemistries (FeCrO, NiCrO and MgAlO).
View Article and Find Full Text PDFProtein-based biologics constitute a rapidly expanding category of therapeutic agents with high target specificity. Their clinical use has dramatically increased in recent years, but administration is largely via injection. Drug delivery across the oral mucosa is a promising alternative to injections, in order to avoid the gastrointestinal tract and first-pass metabolism.
View Article and Find Full Text PDFFibrous mucoadhesive polymer membranes prepared using electrospinning demonstrate many advantages for mucosal drug delivery compared to other formulations. Previous electrospun membrane formulations have been developed mainly for the delivery of small molecule drugs. There remains great potential to further develop the technology for the delivery of vesicular vectors that allow administration of advanced therapeutic agents.
View Article and Find Full Text PDF